Literature DB >> 10379617

Dark spots in late-phase indocyanine green angiographic studies in a patient with presumed ocular histoplasmosis syndrome.

A W Weinberger1, T Kube, S Wolf.   

Abstract

PURPOSE: We analyzed indocyanine green (ICG) angiograms in a patient with presumed ocular histoplasmosis syndrome (POHS) complaining about "seeing spots" and decreased visual acuity in order to identify the pathologic process. PATIENTS AND METHODS: A 30-year-old caucasian man with clinical signs of POHS who had previously undergone laser photocoagulation for secondary choroidal neovascularization developed visual disturbances primarily in his temporal visual field. We performed fundus photography, fluorescein angiography and ICG angiography before, during and after the episode of visual disturbance. ICG angiographic findings were correlated to fundus photographs and fluorescein angiograms.
RESULTS: Fundus examination, fluorescein angiograms and early-phase ICG angiograms were unremarkable at all time points. However, during the phase of visual disturbance, late-phase ICG angiographic study revealed hypofluorescent lesions in the area representing the visual disturbances. At 1 week follow-up, these hypofluorescent lesions were reduced in size and number; at 6 months follow-up they had completely resolved.
CONCLUSIONS: Late-phase ICG angiographic study can provide additional information in inflammatory retinal disease by virtue of identifying areas of choroidal alterations while standard diagnostic examination remain unremarkable.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10379617     DOI: 10.1007/s004170050274

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  3 in total

Review 1.  [Choroiditis].

Authors:  S Thurau; G Wildner
Journal:  Ophthalmologe       Date:  2010-01       Impact factor: 1.059

2.  Age-related scattered hypofluorescent spots on late-phase indocyanine green angiograms.

Authors:  K Shiraki; M Moriwaki; T Kohno; N Yanagihara; T Miki
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

Review 3.  Idiopathic multifocal choroiditis (MFC): aggressive and prolonged therapy with multiple immunosuppressive agents is needed to halt the progression of active disease. An offbeat review and a case series.

Authors:  Ioannis Papasavvas; Piergiorgio Neri; Alessandro Mantovani; Carl P Herbort
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.